Grant Revenue (Details) - USD ($) |
1 Months Ended | 12 Months Ended | 55 Months Ended | ||||
---|---|---|---|---|---|---|---|
Dec. 31, 2019 |
Oct. 31, 2017 |
May 31, 2017 |
Jun. 30, 2016 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2020 |
|
Grant Revenue | |||||||
Revenue | $ 2,947,969 | $ 3,049,104 | |||||
Pelican Therapeutics, Inc. | |||||||
Grant Revenue | |||||||
Contribution to be made by Pelican | 7,600,000 | $ 7,600,000 | |||||
Pelican Therapeutics, Inc. | Maximum | |||||||
Grant Revenue | |||||||
Amount of grant under Grant Contract with CIPRIT | $ 15,200,000 | ||||||
Pelican Therapeutics, Inc. | Tranche 1 | |||||||
Grant Revenue | |||||||
Revenue | $ 1,800,000 | ||||||
Pelican Therapeutics, Inc. | Tranche 2 | |||||||
Grant Revenue | |||||||
Revenue | $ 6,500,000 | ||||||
Pelican Therapeutics, Inc. | Tranche 3 | |||||||
Grant Revenue | |||||||
Revenue | $ 5,400,000 | ||||||
Pelican Therapeutics, Inc. | Grant revenue | |||||||
Grant Revenue | |||||||
Revenue | 13,100,000 | ||||||
Grant receivable | $ 1,500,000 | $ 1,500,000 | |||||
Percentage of contribution | 0.50% | ||||||
Pelican Therapeutics, Inc. | Grant revenue | Maximum | |||||||
Grant Revenue | |||||||
Royalty percentage after threshold is met | 1.00% |
X | ||||||||||
- Definition Amount of grant under Grant Contract with CPRIT. No definition available.
|
X | ||||||||||
- Definition Percentage of contribution to be made by employer. No definition available.
|
X | ||||||||||
- Definition Amount of Contribution to be made in matching funds over the life of a project. No definition available.
|
X | ||||||||||
- Definition Royalty percentage after threshold is met. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|